While they remain an incredibly stigmatized group of patients, those suffering from substance use disorders (SUDs) are finally finding a new breed of treatment centers focused on whole-person care. Eleanor Health is at the forefront of this movement, working to scale an innovative, tech-enabled, and peer-supported platform that supports patients through their recovery by aligning incentives in a value-based payment model. Corbin Petro (WG ’09) is co-founder and CEO of Eleanor. In this episode, we explore Corbin’s path to Eleanor, the unique market forces at play in the substance use disorder market, and Corbin’s perspectives on leading effectively in the COVID-19 era.
The Pulse by Wharton Digital Health